Skip to main content

Table 2 Recommended follow-up for metastatic seminoma and non-seminoma germ cell tumors

From: Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report

  Year 1 Year 2 Year 3–5
Physical examination Q3 months Q3 months Q6 months
Laboratory investigations including tumor markers (AFP, b-HCG, LDH) Q3 months Q3 months Q6 months
CXR Q3 months Q3 months Q6 months
CT abdomen/pelvis Q6 months Q6 months Q12 months
CT chest Q12 months Q12 months Q12 months
  1. AFP alpha-fetoprotein, b-HCG beta- human chorionic gonadotrophin, CT computed tomography, CXR chest X-ray, LDH lactate dehydrogenase, Q every (adopted from the European Association of Urology [5])